Research Evidence
Scientific literature spans several decades with in vitro and in vivo studies. Research published in the Journal of Biomaterials Science showed that GHK-Cu significantly accelerates wound healing by promoting fibroblast proliferation and collagen synthesis.
A comprehensive review in Biomed Research International reported GHK-Cu's potential to modulate over 4,000 genes related to aging and tissue repair, based on Connectivity Map computational analysis rather than direct experimental measurement in human tissue. The study highlighted potential applications in treating age-related conditions and promoting healthy aging.
Key findings from the research literature include:
- Stimulation of collagen I, III, elastin, and glycosaminoglycan synthesis in fibroblasts and skin models
- Modulation of pro-inflammatory cytokines (TNF-α, IL-6, TGF-β) toward anti-inflammatory outcomes
- Upregulation of antioxidant defense genes via copper-dependent SOD activity
- Acceleration of wound re-epithelialization and granulation tissue formation in animal wound models
- Hair follicle enlargement and stimulation of follicle growth in rodent models
The majority of research remains preclinical. Large-scale human clinical trials are absent, which is a significant limitation when drawing conclusions about efficacy and safety in humans.
“The Connectivity Map gene expression data is compelling but should be interpreted carefully — computational predictions of gene modulation are hypothesis-generating, not confirmatory. What we can say with confidence is that the preclinical wound healing and collagen synthesis data is robust and mechanistically well-understood.”
